ERBB2 and neoplasm: While the reasons for HER2 heterogeneity are not clearly elucidated, hypotheses include the development of HER2-amplified neoplastic clones in a largely HER2-negative tumor or the partial silencing of HER2 expression in a homogeneous HER2-positive tumor [90].